Latest Articles
3 FDA Approvals Signal Year of Change for Endometrial Cancer Care - Oncology News Central
3 FDA Approvals Signal Year of Change for Endometrial Cancer Care Oncology News Central
Published: Nov. 13, 2024, 11:41 a.m.
3 FDA Approvals Signal Year of Change for Endometrial Cancer Care - oncologynewscentral.com
3 FDA Approvals Signal Year of Change for Endometrial Cancer Care oncologynewscentral.com
Published: Nov. 13, 2024, 11:41 a.m.
Enhancing Endometrial Cancer Diagnosis with AI and MRI - AZoRobotics
Enhancing Endometrial Cancer Diagnosis with AI and MRI AZoRobotics
Published: Nov. 12, 2024, 10:57 p.m.
Dr Powell on the Implications of the FDA Approval of Dostarlimab for Endometrial Cancer - OncLive
Dr Powell on the Implications of the FDA Approval of Dostarlimab for Endometrial Cancer OncLive
Published: Nov. 7, 2024, 8:04 p.m.
B-Cell Protein Has Both Risk and Protective Factors in Endometrial Cancer - DocWire News
B-Cell Protein Has Both Risk and Protective Factors in Endometrial Cancer DocWire News
Published: Nov. 6, 2024, 7:14 p.m.
Artificial intelligence-assisted magnetic resonance imaging technology in the differential diagnosis and prognosis prediction of endometrial cancer - Nature.com
Artificial intelligence-assisted magnetic resonance imaging technology in the differential diagnosis and prognosis prediction of endometrial cancer Nature.com
Published: Nov. 6, 2024, 5:27 a.m.
Endometrial cancer survivor urges women to be their own health advocate - KEYE TV CBS Austin
Endometrial cancer survivor urges women to be their own health advocate KEYE TV CBS Austin
Published: Nov. 5, 2024, 4:42 p.m.
New Trends of Endometrial Cancer Market To Receive Overwhelming - openPR
New Trends of Endometrial Cancer Market To Receive Overwhelming openPR
Published: Nov. 5, 2024, 2:36 p.m.
Role of HOXA10 in pathologies of the endometrium.
HOXA10 belongs to the homeobox gene family and is essential for uterine biogenesis, endometrial receptivity, embryo implantation, and stromal cell decidualization. Available evidence suggests that the expression of HOXA10 is …
Published: Nov. 5, 2024, midnight
Selinexor May Confer PFS Benefit in TP53 Wild-Type Endometrial Cancer - OncLive
Selinexor May Confer PFS Benefit in TP53 Wild-Type Endometrial Cancer OncLive
Published: Nov. 4, 2024, 8:08 p.m.
Link copied to clipboard!